New Orleans - Topical imiquimod (Aldara) treatment may play a role in preventing UVB-induced cutaneous immunosuppression, Anthony A. Gaspari, M.D., said at the annual meeting of the American Academy of Dermatology.
Establishing a Culture of Respect: Responding to Patient-Initiated Harassment
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity
New Advancements in Surgical Scar Revision
2 Clarke Drive Cranbury, NJ 08512